Cell and Gene Therapy Catapult

For future projects, the Cell and Gene Therapy Catapult are looking at the following:

  • Allogeneic (iPSC) cell therapy and AAV gene therapy development and manufacturing
  • Novel approaches for AAV viral vector production
  • Engineering biology approaches to ATMP development (e.g. iPSC differentiation, viral vector production, cell line optimisation)
  • Next generation analytics for ATMP manufacturing – multi-omics expertise to maximise AAV data mining
  • Novel process analytical technologies (e.g. in-process monitoring)
  • Technologies for improved bioprocess control/scalability
  • Digitisation, automation, digital twins in ATMP manufacturing
  • Sustainability approaches to ATMP manufacturing (e.g. reducing carbon footprint)
  • ATMP formulation and fill/finish

For interest in any of these topics please visit the Cell and Gene Therapy website for further information and get in touch with Asimina Pantazi on asimina.pantazi@ct.catapult.co.uk.

Register for our mailing list for weekly updates on the network and future funding opportunities